Top

Published in:

01-01-2016 | Review Article

Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base

Authors: Kamal K. Mahawar, Chetan Parmar, Yitka Graham, Ayman Abouleid, William R. J. Carr, Neil Jennings, Norbert Schroeder, Peter K. Small

Published in: Obesity Surgery | Issue 1/2016

Abstract

Non-alcoholic fatty liver disease and non-alcoholic steato-hepatitis are common in patients undergoing bariatric surgery. Non-alcoholic steato-hepatitis can progress to cirrhosis of the liver and hepatocellular carcinoma. Non-invasive methods of diagnosing non-alcoholic steato-hepatitis are not as accurate as liver biopsy, and bariatric surgery presents a unique opportunity to carry out a simultaneous liver biopsy. Routine liver biopsy can help early and accurate diagnosis of obesity-associated liver conditions. This has led some surgeons to argue for routine liver biopsy at the time of bariatric surgery. However, most bariatric surgeons remain unconvinced and liver biopsy is currently not routine practice with bariatric surgery. This review examines published scientific literature to ascertain the usefulness of routine liver biopsy at the time of bariatric surgery.

Subichin M, Clanton J, Makuszewski M, et al. Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery. Surg Obes Relat Dis. 2015;11(1):137–41.PubMedCrossRef

Reha JL, Lee S, Hofmann LJ. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience. Am Surg. 2014;80(6):595–9.PubMed

Losekann A, Weston AC, Carli LA, et al. Nonalcoholic fatty liver disease in severe obese patients, subjected to bariatric surgery. Arq Gastroenterol. 2013;50(4):285–9.PubMedCrossRef

Praveenraj P, Gomes RM, Kumar S, et al. Prevalence and predictors of non-alcoholic fatty liver disease in morbidly obese South Indian patients undergoing bariatric surgery. Obes Surg. 2015.

Seki Y, Kakizaki S, Horiguchi N, et al. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. J Gastroenterol. 2015.

Teixeira AR, Bellodi-Privato M, Carvalheira JB, et al. The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory. Obes Surg. 2009;19(12):1678–84.PubMedCrossRef

Shalhub S, Parsee A, Gallagher SF, et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg. 2004;14(1):54–9.PubMedCrossRef

Dolce CJ, Russo M, Keller JE, et al. Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. Surg Obes Relat Dis. 2009;5(3):323–8.PubMedCrossRef

Verna EC. Liver biopsy at the time of bariatric surgery: a benefit for patients and the medical community. Semin Liver Dis. 2014;34(1):1–6.PubMedCrossRef

10.

Dallal RM, Samuel G, Lord JL, et al. Hemobilia: a rare complication after routine liver biopsy during gastric bypass. Surg Obes Relat Dis. 2007;3(1):91–3.PubMedCrossRef

11.

Quezada N, León F, Martínez J, et al. Emergency right hepatectomy after laparoscopic tru-cut liver biopsy. Int J Surg Case Rep. 2015;8C:42–4.PubMedCrossRef

12.

Denzer U, Arnoldy A, Kanzler S, et al. Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: diagnosis of cirrhosis and complications. J Clin Gastroenterol. 2007;41(1):103–10.PubMedCrossRef

13.

Bellentani S, Scaglioni F, Marino M, et al. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):155–61.PubMedCrossRef

14.

Sasaki A, Nitta H, Otsuka K, et al. Bariatric surgery and non-alcoholic fatty liver disease: current and potential future treatments. Front Endocrinol (Lausanne). 2014;5:164.

15.

Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol. 2011;46 Suppl 1:63–9.PubMedCrossRef

16.

Sanyal AJ, Brunt EM, Kleiner DE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54(1):344–53.PubMedPubMedCentralCrossRef

17.

Hyysalo J, Männistö VT, Zhou Y, et al. A population-based study on the prevalence of NASH using scores validated against liver histology. J Hepatol. 2014;60(4):839–46.PubMedCrossRef

18.

Hu KC, Wang HY, Liu SC, et al. Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol. 2014;20(24):7718–29.PubMedPubMedCentralCrossRef

19.

Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014;5(3):211–8.PubMedPubMedCentralCrossRef

20.

Campos GM, Bambha K, Vittinghoff E, et al. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. Hepatology. 2008;47(6):1916–23.PubMedCrossRef

21.

Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 2012;107(6):811–26.PubMedCrossRef

22.

Jan A, Narwaria M, Mahawar KK. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.PubMedCrossRef

23.

Helmreich-Becker I, Schirmacher P, Denzer U, et al. Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease. Endoscopy. 2003;35(1):55–60.PubMedCrossRef

24.

Jalan R, Harrison DJ, Dillon JF, et al. Laparoscopy and histology in the diagnosis of chronic liver disease. QJM. 1995;88(8):559–64.PubMed

25.

Crantock LR, Dillon JF, Hayes PC. Diagnostic laparoscopy and liver disease: experience of 200 cases. Aust N Z J Med. 1994;24(3):258–62.PubMedCrossRef

26.

Poniachik J, Bernstein DE, Reddy KR, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc. 1996;43(6):568–71.PubMedCrossRef

27.

Pagliaro L, Rinaldi F, Craxì A, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci. 1983;28(1):39–43.PubMedCrossRef

28.

Weickert U, Siegel E, Schilling D, et al. The diagnosis of liver cirrhosis: a comparative evaluation of standard laparoscopy, mini-laparoscopy and histology. Z Gastroenterol. 2005;43(1):17–21.PubMedCrossRef

29.

Cazzo E, Jimenez LS, Pareja JC, et al. Effect of Roux-en-y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study. Obes Surg. 2014.

30.

Furuya Jr CK, de Oliveira CP, de Mello ES, et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol. 2007;22(4):510–4.PubMedCrossRef

31.

Weiner RA. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):274–9.PubMedCrossRef

32.

de Almeida SR, Rocha PR, Sanches MD, et al. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obes Surg. 2006;16(3):270–8.PubMedCrossRef

33.

Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149(2):379–88.PubMedCrossRef

34.

Praveen Raj P, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surg Obes Relat Dis. 2015. doi:10.1016/j.soard.2015.02.006.PubMed

35.

Taitano AA, Markow M, Finan JE, et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg. 2015;19(3):429–36.PubMedCrossRef

36.

Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396–402.PubMedCrossRef

37.

Estep JM, Birerdinc A, Younossi Z. Non-invasive diagnostic tests for non-alcoholic fatty liver disease. Curr Mol Med. 2010;10(2):166–72.PubMedCrossRef

38.

Haydon GH, Hayes PC. Diagnostic laparoscopy by physicians: we should do it. QJM. 1997;90(4):297–304.PubMedCrossRef

39.

Ramos-De la Medina A, Remes-Troche JM, Roesch-Dietlen FB, et al. Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg. 2008;12(12):2097–102.PubMedCrossRef

40.

Zuegel NP, Hehl JA, Auerbach-Heber K, et al. Value of liver biopsy combined with cholecystectomy. Hepatogastroenterology. 1999;46(30):3095–8.PubMed

41.

Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;1, CD007340.PubMed

42.

Younossi ZM, Reyes MJ, Mishra A, et al. Systematic review with meta-analysis: non-alcoholic steatohepatitis—a case for personalised treatment based on pathogenic targets. Aliment Pharmacol Ther. 2014;39(1):3–14.PubMedCrossRef

43.

Nascimbeni F, Pais R, Bellentani S, et al. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59(4):859–71.PubMedCrossRef

44.

Ratziu V, Bellentani S, Cortez-Pinto H, et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53(2):372–84.PubMedCrossRef

45.

British Society of Gastroenterology: guidelines on the use of liver biopsy in clinical practice. http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/liver/liver_biopsy.pdf Accessed 12 Apr 2015.

46.

British Society of Gastroenterology: chronic management of NASH/NAFLD. http://www.bsg.org.uk/images/Commissioning_report/BSG_NASH_and_Non-Alcoholic_Fatty_Liver_Disease.pdf Accessed 12 Apr 2015.

Title: Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base
Authors: Kamal K. Mahawar
Chetan Parmar
Yitka Graham
Ayman Abouleid
William R. J. Carr
Neil Jennings
Norbert Schroeder
Peter K. Small
Publication date: 01-01-2016
Publisher: Springer US
Published in: Obesity Surgery / Issue 1/2016
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-015-1916-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Management of Excessive Weight Loss Following Laparoscopic Roux-en-Y Gastric Bypass: Clinical Algorithm and Surgical Techniques

Metabolic Surgery Could Restore Hepatic Glucose Metabolism: Results from F-18 Fluorodeoxyglucose Positron Emission Tomography

Comparison Between Banded and Nonbanded Roux-En-Y Gastric Bypass with 2-Year Follow-Up: a Preliminary Retrospective Analysis

Antecolic or Retrocolic Alimentary Limb in Laparoscopic Roux-en-Y Gastric Bypass? A Meta-Analysis

Long-term Weight and Metabolic Effects of Laparoscopic Sleeve Gastrectomy Calibrated with a 50-Fr Bougie

The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis